Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
47.73 CAD | -1.63% | -0.33% | -8.51% |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 2.4TCr | 2.29TCr | 2.34TCr | 2.42TCr | 2.47TCr | |||||
Total Revenues | 2.4TCr | 2.29TCr | 2.34TCr | 2.42TCr | 2.47TCr | |||||
Cost of Goods Sold, Total | 1.37TCr | 1.31TCr | 1.34TCr | 1.37TCr | 1.38TCr | |||||
Gross Profit | 1.03TCr | 980.2Cr | 1.01TCr | 1.05TCr | 1.08TCr | |||||
Selling General & Admin Expenses, Total | 25Cr | 24Cr | 21Cr | 22Cr | 22Cr | |||||
R&D Expenses | - | - | - | - | 9Cr | |||||
Depreciation & Amortization - (IS) | 349.6Cr | 347.5Cr | 362.7Cr | 366Cr | 374.5Cr | |||||
Amortization of Goodwill and Intangible Assets - (IS) | 90Cr | 93Cr | 98Cr | 106.3Cr | 117.3Cr | |||||
Other Operating Expenses, Total | 464.7Cr | 464.5Cr | 482.2Cr | 494.3Cr | 522.6Cr | |||||
Operating Income | 564.5Cr | 515.7Cr | 526.4Cr | 552.7Cr | 560.7Cr | |||||
Interest Expense, Total | -113.2Cr | -111Cr | -108.2Cr | -114.6Cr | -147.5Cr | |||||
Interest And Investment Income | - | - | - | - | 6.7Cr | |||||
Net Interest Expenses | -113.2Cr | -111Cr | -108.2Cr | -114.6Cr | -140.8Cr | |||||
Income (Loss) On Equity Invest. | -7.2Cr | 50L | -9.5Cr | -6.1Cr | -55Cr | |||||
Other Non Operating Income (Expenses) | 18Cr | -6.9Cr | 34Cr | -3.3Cr | -7Cr | |||||
EBT, Excl. Unusual Items | 461.6Cr | 398.3Cr | 442.5Cr | 428.7Cr | 357.6Cr | |||||
Restructuring Charges | -6.3Cr | -3.5Cr | -17Cr | -8.3Cr | -13Cr | |||||
Merger & Related Restructuring Charges | -5.1Cr | -8.1Cr | -3.8Cr | -1.1Cr | -6.6Cr | |||||
Gain (Loss) On Sale Of Investments | 1.3Cr | 30L | -60L | 2.4Cr | 8Cr | |||||
Gain (Loss) On Sale Of Assets | - | - | - | - | - | |||||
Asset Writedown | -11Cr | -56Cr | -22Cr | -31Cr | -13Cr | |||||
Legal Settlements | - | - | - | - | - | |||||
Other Unusual Items | -1.8Cr | -5Cr | -5.3Cr | -1.8Cr | -10L | |||||
EBT, Incl. Unusual Items | 438.6Cr | 326.5Cr | 393.6Cr | 389.3Cr | 332.3Cr | |||||
Income Tax Expense | 113.3Cr | 79Cr | 104.4Cr | 97Cr | 100Cr | |||||
Earnings From Continuing Operations | 325.3Cr | 247.3Cr | 289.2Cr | 292.6Cr | 232.7Cr | |||||
Earnings Of Discontinued Operations | - | 23Cr | - | - | - | |||||
Net Income to Company | 325.3Cr | 269.9Cr | 289.2Cr | 292.6Cr | 232.7Cr | |||||
Minority Interest | -6.2Cr | -6.5Cr | -5.2Cr | -5.8Cr | -6.4Cr | |||||
Net Income - (IS) | 319.1Cr | 263.4Cr | 284Cr | 286.8Cr | 226.3Cr | |||||
Preferred Dividend and Other Adjustments | 15Cr | 14Cr | 13Cr | 15Cr | 19Cr | |||||
Net Income to Common Incl Extra Items | 304Cr | 249.8Cr | 270.9Cr | 271.6Cr | 207.6Cr | |||||
Net Income to Common Excl. Extra Items | 304Cr | 227.2Cr | 270.9Cr | 271.6Cr | 207.6Cr | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 3.37 | 2.76 | 2.99 | 2.98 | 2.28 | |||||
Basic EPS - Continuing Operations | 3.37 | 2.51 | 2.99 | 2.98 | 2.28 | |||||
Basic Weighted Average Shares Outstanding | 90Cr | 90Cr | 91Cr | 91Cr | 91Cr | |||||
Net EPS - Diluted | 3.37 | 2.76 | 2.99 | 2.98 | 2.28 | |||||
Diluted EPS - Continuing Operations | 3.37 | 2.51 | 2.99 | 2.98 | 2.28 | |||||
Diluted Weighted Average Shares Outstanding | 90Cr | 90Cr | 91Cr | 91Cr | 91Cr | |||||
Normalized Basic EPS | 3.13 | 2.68 | 2.99 | 2.88 | 2.38 | |||||
Normalized Diluted EPS | 3.13 | 2.68 | 2.99 | 2.87 | 2.38 | |||||
Dividend Per Share | 3.17 | 3.33 | 3.5 | 3.68 | 3.87 | |||||
Payout Ratio | 92.95 | 117.96 | 114.68 | 120.22 | 162.09 | |||||
Supplemental Items | ||||||||||
EBITDA | 862.2Cr | 810.3Cr | 832.8Cr | 861.5Cr | 870.3Cr | |||||
EBITA | 580.2Cr | 529.9Cr | 539.5Cr | 566.4Cr | 574.7Cr | |||||
EBIT | 564.5Cr | 515.7Cr | 526.4Cr | 552.7Cr | 560.7Cr | |||||
EBITDAR | 887.1Cr | 834.4Cr | 854.1Cr | 883.5Cr | 892.1Cr | |||||
Effective Tax Rate - (Ratio) | 25.83 | 24.26 | 26.52 | 24.84 | 29.97 | |||||
Current Domestic Taxes | - | - | - | - | - | |||||
Total Current Taxes | 73Cr | 68Cr | 82Cr | 78Cr | 91Cr | |||||
Deferred Domestic Taxes | - | - | - | - | - | |||||
Total Deferred Taxes | 40Cr | 11Cr | 23Cr | 19Cr | 9Cr | |||||
Normalized Net Income | 282.3Cr | 242.44Cr | 271.36Cr | 262.14Cr | 217.1Cr | |||||
Interest Capitalized | 4.5Cr | 4.9Cr | 6.3Cr | 13Cr | 14Cr | |||||
Interest on Long-Term Debt | 102.4Cr | 107.2Cr | 108.8Cr | 114.8Cr | 139.1Cr | |||||
Non-Cash Pension Expense | 1.9Cr | 1Cr | -1.1Cr | -10Cr | -20Cr | |||||
Supplemental Operating Expense Items | ||||||||||
Research And Development Expense From Footnotes | 11Cr | 4.7Cr | 5.7Cr | 5.7Cr | 9Cr | |||||
Net Rental Expense, Total | 25Cr | 24Cr | 21Cr | 22Cr | 22Cr | |||||
Imputed Operating Lease Interest Expense | 9.25Cr | 8.49Cr | 6.97Cr | 7.28Cr | 8.25Cr | |||||
Imputed Operating Lease Depreciation | 16Cr | 16Cr | 14Cr | 15Cr | 14Cr | |||||
Stock-Based Comp., COGS (Total) | 9.3Cr | 9.1Cr | 9.5Cr | 10Cr | 9.5Cr | |||||
Total Stock-Based Compensation | 9.3Cr | 9.1Cr | 9.5Cr | 10Cr | 9.5Cr |